Esperion Investors
menu
Esperion Investors
close x
  • About
    • Company
    • Leadership
    • Collaborations
    • Contact
  • Programs
    • Pipeline
    • Development Strategy
    • Clinical Trials
  • Science
    • microRNA Platform
    • Therapeutic Areas
    • Scientific Publications
  • Careers
    • Culture & Values
    • Job Openings
  • Investors
    • Press Releases
    • Events
    • Presentations
    • Corporate Governance
      • Leadership
      • Committee Composition
    • Financials and Filings
    • Stock Information
    • Information Request
    • Press Releases
    • Events
    • Presentations
    • Corporate Governance
      • Leadership
      • Committee Composition
    • Financials and Filings
    • Stock Information
    • Information Request
    • Press Releases
    • Events
    • Presentations
    • Corporate Governance
      • Leadership
      • Committee Composition
    • Financials and Filings
    • Stock Information
    • Information Request
  • Patients
    • Clinical Trials Overview
    • Cutaneous T-Cell Lymphoma (CTCL)
    • Adult T-Cell Lymphoma/Leukemia (ATLL)
    • Diffuse Large B-Cell Lymphoma (DLBCL)
    • Chronic Lymphocytic Leukemia (CLL)
    • Keloids
  • Clinicians
    • miRagen Clinical Trials
    • Cutaneous T-cell Lymphoma (CTCL), MF Subtype – Cobomarsen SOLAR Clinical Trial
    • ATLL, CLL and DLBCL – Cobomarsen Phase 1 Clinical Trial
    • Keloids – Remlarsen Phase 2 Clinical Trial
    • Revascularization – MRG-110 Phase 1 Clinical Trials

Investors

  • Follow mIRagen
  • @miRagenRx
  • miRagen

Contact

miRagen Therapeutics 6200 Lookout Rd. Boulder, CO 80301 T: 720.643.5200 F: 720.643.5201 info@miragenrx.com

Presentations

MGEN $0.60 $ + 0.02 (3.28%)
Notify me of new presentations posted to this site.
6/4/2019
Jefferies 2019 Healthcare Conference
3/20/2019
Oppenheimer 29th Annual Healthcare Conference
11/15/2018
Jefferies London Healthcare Conference
8/14/2018
Wedbush Pacgrow Healthcare Conference
6/7/2018
Jefferies Global Healthcare Conference
5/23/2018
UBS Global Healthcare Conference
5/8/2018
Deutsche Bank 43rd Annual Health Care Conference
3/27/2018
Needham 17th Annual Healthcare Conference
3/20/2018
Oppenheimer 28th Annual Healthcare Conference
3/13/2018
Cowen and Company 38th Annual Health Care Conference
2/15/2018
Miragen Investor Presentation
11/29/2017
29th Annual Piper Jaffray Healthcare Conference
11/16/2017
Jeffries 2017 London Healthcare Conference
11/14/2017
Stifel 2017 Healthcare Conference
9/26/2017
Cantor Global Healthcare Conference
8/15/2017
Wedbush PacGrow Healthcare Conference
6/8/2017
Jefferies Healthcare Conference Presentation
5/22/2017
UBS Healthcare Conference Presentation
5/3/2017
Deutsche Bank 42nd Annual Health Care Conference
4/4/2017
Needham and Company 16th Annual Healthcare Conference Presentation
3/7/2017
Cowen and Company 37th Annual Health Care Conference

Click the link to the right to download: Adobe Acrobat
About Us
  • Company
  • Leadership
  • Collaborations
  • Contact
Our Programs
  • Pipeline
  • Development Strategy
  • Clinical Trials
Our Science
  • microRNA Platform
  • Therapeutic Areas
  • Scientific Publications
Careers
  • Culture & Values
  • Job Openings
Investors & Media
  • Press Releases
  • Events
  • Presentations
  • Corporate Governance
  • Financials and Filings
  • Stock Information
  • Information Request
Esperion Investors
Follow Us
Copyright © 2019 miRagen Therapeutics. All Rights Reserved. Privacy Policy